Inhibition of SRPK1, a key splicing regulator, exhibits antitumor and chemotherapeutic-sensitizing effects on extranodal NK/T-cell lymphoma cells by Cuiying He https://t.co/FTMffjPbSO
1,384 followers
2,454 followers
Inhibition of SRPK1, a key splicing regulator, exhibits antitumor and chemotherapeutic-sensitizing effects on extranodal NK/T-cell lymphoma cells #lymphoma #lymsm https://t.co/wt4tCyYnCO
925 followers
New article: Inhibition of SRPK1, a key splicing regulator, exhibits antitumor and chemotherapeutic-sensitizing effects on extranodal NK/T-cell lymphoma cells https://t.co/CMbMp0hcoL #TCL #lymsm #hematology https://t.co/6dbphDf4e5